These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38344665)

  • 21. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
    Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
    Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Safety and effect of transurethral holmium laser enucleation of the prostate versus bipolar transurethral plasmakinetic prostatectomy for benign prostatic hyperplasia: A meta-analysis].
    Guo Q; Xiao Y; Li JW; Zhang JD; Zhang YG
    Zhonghua Nan Ke Xue; 2016 Oct; 22(10):914-922. PubMed ID: 29278474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
    Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
    J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency.
    Vartolomei MD; Kimura S; Vartolomei L; Shariat SF
    Eur Urol Focus; 2020 Jan; 6(1):170-177. PubMed ID: 30017901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis.
    Hudson J; Cruickshank M; Quinton R; Aucott L; Wu F; Grossmann M; Bhasin S; Snyder PJ; Ellenberg SS; Travison TG; Brock GB; Gianatti EJ; van der Schouw YT; Emmelot-Vonk MH; Giltay EJ; Hackett G; Ramachandran S; Svartberg J; Hildreth KL; Antonic KG; Tenover JL; Tan HM; Ho Chee Kong C; Tan WS; Marks LS; Ross RJ; Schwartz RS; Manson P; Roberts SA; Skovsager Andersen M; Velling Magnussen L; Aceves-Martins M; Gillies K; Hernández R; Oliver N; Dhillo WS; Bhattacharya S; Brazzelli M; Jayasena CN
    Lancet Healthy Longev; 2023 Oct; 4(10):e561-e572. PubMed ID: 37804846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update in testosterone therapy for men.
    Corona G; Rastrelli G; Forti G; Maggi M
    J Sex Med; 2011 Mar; 8(3):639-54; quiz 655. PubMed ID: 21711483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies.
    Lai S; Peng P; Diao T; Hou H; Wang X; Zhang W; Liu M; Zhang Y; Seery S; Wang J
    BMJ Open; 2019 Aug; 9(8):e028855. PubMed ID: 31439603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of Testosterone Replacement Therapy on Penile Hemodynamics in Hypogonadal Men With Erectile Dysfunction, Having Veno-Occlusive Dysfunction.
    Efesoy O; Çayan S; Akbay E
    Am J Mens Health; 2018 May; 12(3):634-638. PubMed ID: 29575969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
    Rhoden EL; Morgentaler A
    Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism.
    Almehmadi Y; Yassin AA; Nettleship JE; Saad F
    Arab J Urol; 2016 Mar; 14(1):31-6. PubMed ID: 26966591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erectile Dysfunction in Comparison with Monotherapy: A Systematic Review and Meta-analysis.
    Kallidonis P; Adamou C; Kotsiris D; Ntasiotis P; Verze P; Athanasopoulos A;
    Eur Urol Focus; 2020 May; 6(3):537-558. PubMed ID: 31133414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Testosterone Replacement Therapy on Muscle Strength in Older Men with Low to Low-Normal Testosterone Levels: A Systematic Review and Meta-Analysis.
    Lee TW; Kao PY; Chen YC; Wang ST
    Gerontology; 2023; 69(10):1157-1166. PubMed ID: 37494893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.
    Lazarou S; Morgentaler A
    Curr Urol Rep; 2005 Nov; 6(6):476-81. PubMed ID: 16238923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
    Kaplan AL; Lenis AT; Shah A; Rajfer J; Hu JC
    J Sex Med; 2015 Feb; 12(2):374-80. PubMed ID: 25496237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect and safety of testosterone undecanoate in the treatment of late-onset hypogonadism: a meta-analysis].
    Zheng Y; Shen XB; Zhou YZ; Ma J; Shang XJ; Shi YJ
    Zhonghua Nan Ke Xue; 2015 Mar; 21(3):263-71. PubMed ID: 25898560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology.
    Corona G; Goulis DG; Huhtaniemi I; Zitzmann M; Toppari J; Forti G; Vanderschueren D; Wu FC
    Andrology; 2020 Sep; 8(5):970-987. PubMed ID: 32026626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism.
    Efesoy O; Apa D; Tek M; Çayan S
    Aging Male; 2016 Jun; 19(2):79-84. PubMed ID: 26927833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men.
    Maggi M; Heiselman D; Knorr J; Iyengar S; Paduch DA; Donatucci CF
    J Sex Med; 2016 Aug; 13(8):1220-6. PubMed ID: 27436077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: a pilot study.
    Shamloul R; Ghanem H; Fahmy I; El-Meleigy A; Ashoor S; Elnashaar A; Kamel I
    J Sex Med; 2005 Jul; 2(4):559-64. PubMed ID: 16422854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.